Skip to content
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
  • Products & Services
    • SEQ
    • Covid19-qPCR
    • Pathogenicity Calculator
  • Our Company
    • About Us
    • Careers
    • News & Events
    • Contact Us
    • Certifications & Compliances
  • Science Hub
    • Blog
    • White Papers
    • Citations
Sign In to SEQ
Schedule A Demo

Orange document icon with pencil

The Incidence of Cystic Fibrosis in the Central Region of Anatolia in Turkey Between 2015 and 2016

Balkan Medical Journal, 2019By Ahmet Can TurkogluMay 10, 2019

Hangül et al. (2019) applied Genomize-SEQ for CFTR variant analysis across 119,006 newborns in central Anatolia, establishing a CF incidence of 1 in 3,400 live births, the first Turkish estimate from national newborn screening.

Orange document icon with pencil

Targeted Next-Generation Sequencing of MLH1, MSH2, and MSH6 Genes in Patients with Endometrial Carcinoma under 50 Years of Age

Balkan Medical Journal, 2019By Ahmet Can TurkogluJanuary 1, 2019

Özdemir et al. (2019) used Genomize-SEQ to analyze MMR gene variants in 79 endometrial cancer patients under 50, confirming Lynch syndrome in 5% of cases and identifying three novel pathogenic mutations for the first time in Turkey.

Genomize_logo
info@genomize.com
Linkedin Facebook Twitter Instagram

Products & Services

  • SEQ Platform
  • Covid19-qPCR
  • Pathogenicity Calculator

Our Company

  • About Us
  • Careers
  • Contact Us
  • Certifications & Compliances

Science Hub

  • Blog
  • White Papers
  • Citations
© 2026 Genomize. All rights reserved.
Go to Top